How This Rare Metal Is Going To Solve A $173 TRILLION World Problem… And Could Benefit Investors
According to Bloomberg NEF, changing the world to "All Green Energy" could cost about $173 trillion. And without this rare metal, going green would be IMPOSSIBLE. That's why there's a literal "gold rush" to find it. (HINT: It's not electric vehicles, nuclear power, or wind energy).
Show Me How This Industry Could Explode!

ABIO Insider Trading (ARCA biopharma)

Insider Ownership Percentage: 0.48%
Insider Buying (Last 12 Months): $218,800.00
Insider Selling (Last 12 Months): $0.00

ARCA biopharma Insider Trading History Chart

This chart shows the insider buying and selling history at ARCA biopharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ARCA biopharma Share Price & Price History

Current Price: $2.43
Price Change: Price Decrease of -0.18 (-6.90%)
As of 11/29/2021 02:25 PM ET

This chart shows the closing price history over time for ABIO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
2021 Investor Alert: Amazon, Google, And Facebook Stockpile Strange Gas
This odorless, colorless gas is critical for every piece of technology you own. However, the world's supply is running dangerously low. This is the time for investors to get in before the mainstream media.
Click HERE To See Why Big Tech Is Hoarding Gas

ARCA biopharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/22/2021Christopher David OzeroffVPBuy50,000$2.26$113,000.00View SEC Filing Icon  
5/12/2021Robert E ConwayChairmanBuy10,000$3.19$31,900.0050,000View SEC Filing Icon  
5/5/2021Robert E ConwayChairmanBuy10,000$3.23$32,300.0040,000View SEC Filing Icon  
12/18/2020Robert E ConwayChairmanBuy10,000$4.16$41,600.0030,000View SEC Filing Icon  
9/25/2020Robert E ConwayChairmanBuy5,000$4.28$21,400.0020,000View SEC Filing Icon  
9/21/2020Robert E ConwayChairmanBuy10,000$4.77$47,700.0011,944View SEC Filing Icon  
See Full Table
Insider Trading at ARCA biopharma?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for ARCA biopharma and related companies.

SEC Filings (Institutional Ownership Changes) for ARCA biopharma (NASDAQ:ABIO)

8.28% of ARCA biopharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ABIO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

ARCA biopharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2021Millennium Management LLC15,874$47K0.0%N/A0.110%Search for SEC Filing on Google Icon
11/15/2021GSA Capital Partners LLP441,945$1.31M0.1%+238.9%3.067%Search for SEC Filing on Google Icon
11/15/2021Minerva Advisors LLC10,000$30K0.0%N/A0.069%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC95,358$0.28M0.0%+8.8%0.662%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.268,394$0.80M0.0%-1.8%1.863%Search for SEC Filing on Google Icon
8/16/2021State Street Corp69,037$0.24M0.0%N/A0.479%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.13,918$49K0.0%N/A0.097%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC87,659$0.31M0.0%+10.7%0.608%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.398,507$1.39M0.0%+189.8%2.765%Search for SEC Filing on Google Icon
8/12/2021XTX Topco Ltd10,846$38K0.0%N/A0.075%Search for SEC Filing on Google Icon
8/5/2021GSA Capital Partners LLP130,395$0.46M0.1%+39.8%0.905%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC16,655$61K0.0%-32.4%0.116%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley40,744$0.15M0.0%+952.5%0.283%Search for SEC Filing on Google Icon
5/17/2021PDT Partners LLC17,297$63K0.0%N/A0.120%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC79,151$0.29M0.0%+141.7%0.549%Search for SEC Filing on Google Icon
5/10/2021GSA Capital Partners LLP93,241$0.34M0.1%+102.3%0.647%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC24,641$99K0.0%N/A0.264%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC205,500$0.82M0.0%+436.4%2.205%Search for SEC Filing on Google Icon
2/10/2021Panagora Asset Management Inc.6,878$28K0.0%N/A0.074%Search for SEC Filing on Google Icon
2/4/2021GSA Capital Partners LLP46,097$0.19M0.0%N/A0.495%Search for SEC Filing on Google Icon
11/19/2020Schonfeld Strategic Advisors LLC18,200$80K0.0%N/A0.195%Search for SEC Filing on Google Icon
11/17/2020Schonfeld Strategic Advisors LLC18,200$80K0.0%N/A0.195%Search for SEC Filing on Google Icon
11/6/2020BlackRock Inc.287,263$1.27M0.0%+598,364.6%4.865%Search for SEC Filing on Google Icon
8/13/2020Tekla Capital Management LLC32,461$0.22M0.0%-10.0%0.550%Search for SEC Filing on Google Icon
5/11/2020Acadian Asset Management LLC28,423$80K0.0%+64.0%1.788%Search for SEC Filing on Google Icon
2/13/2020Renaissance Technologies LLC142,572$0.81M0.0%+42.4%8.944%Search for SEC Filing on Google Icon
8/12/2019Renaissance Technologies LLC80,485$0.59M0.0%-91.1%5.528%Search for SEC Filing on Google Icon
8/12/2019Quantamental Technologies LLC5,148$38K0.0%N/A0.353%Search for SEC Filing on Google Icon
8/8/2019Acadian Asset Management LLC17,333$0.13M0.0%-92.1%1.187%Search for SEC Filing on Google Icon
8/6/2019Aveo Capital Partners LLC95,715$0.66M0.3%+2.6%6.574%Search for SEC Filing on Google Icon
11/13/2018Renaissance Technologies LLC670,459$0.38M0.0%+59.9%4.817%Search for SEC Filing on Google Icon
11/13/2018Virtu Financial LLC176,131$0.54M0.0%+416.1%1.265%Search for SEC Filing on Google Icon
8/13/2018Renaissance Technologies LLC419,250$0.23M0.0%-21.4%3.012%Search for SEC Filing on Google Icon
2/13/2018Renaissance Technologies LLC129,705$0.18M0.0%-45.2%1.104%Search for SEC Filing on Google Icon
2/9/2018Royce & Associates LP324,847$0.45M0.0%+38.3%2.765%Search for SEC Filing on Google Icon
11/14/2017Royce & Associates LP234,847$0.26M0.0%+30.6%1.999%Search for SEC Filing on Google Icon
8/14/2017Tekla Capital Management LLC811,227$1.99M0.1%No Change6.904%Search for SEC Filing on Google Icon
8/10/2017Franklin Resources Inc.1,216,840$2.98M0.0%No Change13.166%Search for SEC Filing on Google Icon
8/7/2017Royce & Associates LP179,847$0.44M0.0%+476.4%1.946%Search for SEC Filing on Google Icon
8/1/2017Aveo Capital Partners LLC93,667$0.23M0.1%+93.7%1.013%Search for SEC Filing on Google Icon
7/26/2017NEA Management Company LLC1,460,209$3.51M0.1%No Change15.800%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
ARCA biopharma logo
ARCA biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of targeted therapies for cardiovascular diseases. The firm focuses on the cardiovascular pathophysiology, molecular genetics, and clinical development. Its product candidate, Gencaro is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.
Read More on ARCA biopharma

Today's Range

Now: $2.43
Low: $2.42
High: $2.48

50 Day Range

MA: $2.69
Low: $2.23
High: $3.02

52 Week Range

Now: $2.43
Low: $2.17
High: $5.50

Volume

555 shs

Average Volume

519,007 shs

Market Capitalization

$35.02 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.5

Who are the company insiders with the largest holdings of ARCA biopharma?

ARCA biopharma's top insider investors include:
  1. Robert E Conway (Chairman)
  2. Christopher David Ozeroff (VP)

Who are the major institutional investors of ARCA biopharma?

ARCA biopharma's top institutional shareholders include:
  1. GSA Capital Partners LLP — 3.07%
  2. BlackRock Inc. — 1.86%
  3. Geode Capital Management LLC — 0.66%
  4. Citadel Advisors LLC — 0.00%
  5. Millennium Management LLC — 0.11%
  6. Minerva Advisors LLC — 0.07%

Which major investors are selling ARCA biopharma stock?

During the last quarter, ABIO stock was sold by these institutional investors:
  1. BlackRock Inc.

Which major investors are buying ARCA biopharma stock?

Within the previous quarter, ABIO stock was bought by institutional investors including:
  1. GSA Capital Partners LLP
  2. Citadel Advisors LLC
  3. Millennium Management LLC
  4. Minerva Advisors LLC
  5. Geode Capital Management LLC
Within the previous year, these company insiders have bought ARCA biopharma stock:
  1. Robert E Conway (Chairman)
  2. Christopher David Ozeroff (VP)
2021 Investor Alert: Amazon, Google, And Facebook Stockpile Strange Gas
This odorless, colorless gas is critical for every piece of technology you own. However, the world's supply is running dangerously low. This is the time for investors to get in before the mainstream media.
Click HERE To See Why Big Tech Is Hoarding Gas